A Family of 16-kDa Pancreatic Secretory Stress Proteins Form Highly Organized Fibrillar Structures upon Tryptic Activation*

Rolf GrafDagger, Marc Schiesser, George A. Scheele§, Klaus Marquardt, Thomas W. Frick, Rudolf W. Ammann||, and Daniel Bimmler

From the Pancreatitis Research Laboratory, Department of Visceral and Transplantation Surgery, University Hospital, Zürich, 8091, Switzerland, § Institute of Genomic Medicine, La Jolla, California 92037,  Chirurgie, Spital Zollikerberg, 8125, Zollikerberg, and || Division of Gastroenterology, Department of Internal Medicine, University Hospital, Zürich, 8091, Switzerland

Received for publication, November 28, 2000, and in revised form, February 7, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A group of 16-kDa proteins, synthesized and secreted by rat pancreatic acinar cells and composed of pancreatic stone protein (PSP/reg) and isoforms of pancreatitis-associated protein (PAP), show structural homologies, including conserved amino acid sequences, cysteine residues, and highly sensitive N-terminal trypsin cleavage sites, as well as conserved functional responses in conditions of pancreatic stress. Trypsin activation of recombinant stress proteins or counterparts contained in rat pancreatic juice (PSP/reg, PAP I and PAP III) resulted in conversion of 16-kDa soluble proteins into 14-kDa soluble isoforms (pancreatic thread protein and pancreatitis-associated thread protein, respectively) that rapidly polymerize into insoluble sedimenting structures. Activated thread proteins show long lived resistance to a wide spectrum of proteases contained in pancreatic juice, including serine proteases and metalloproteinases. In contrast, PAP II, following activation with trypsin or pancreatic juice, does not form insoluble structures and is rapidly digested by pancreatic proteases. Scanning and transmission electron microscopy indicate that activated thread proteins polymerize into highly organized fibrillar structures with helical configurations. Through bundling, branching, and extension processes, these fibrillar structures form dense matrices that span large topological surfaces. These findings suggest that PSP/reg and PAP I and III isoforms consist of a family of highly regulated soluble secretory stress proteins, which, upon trypsin activation, convert into a family of insoluble helical thread proteins. Dense extracellular matrices, composed of helical thread proteins organized into higher ordered matrix structures, may serve physiological functions within luminal compartments in the exocrine pancreas.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Pancreatic juice in vertebrates contains a group of 16-kDa proteins without known enzyme, proenzyme, or inhibitor function in the digestive process. This group, without defined function, is composed of the following protein species. Pancreatic stone protein (PSP/reg)1 is a 16-kDa acidic protein with an isoelectric point in the range of pH 5.5-6. A truncated form of this protein was originally isolated from calcium carbonate stones surgically removed from the main pancreatic duct of humans with chronic pancreatitis (1). For several years it was believed that PSP/reg served as an inhibitor of calcium carbonate precipitation in pancreatic juice, and it was proposed that its name should be changed to "lithostathine" (2). However, it was later shown that PSP/reg has no more crystal inhibitory activity than several of the pancreatic digestive enzymes (3, 4). Other studies have demonstrated that the expression of PSP/reg protein is increased during the regeneration of islets after nicotinamide treatment and partial pancreatectomy (5, 6). These observations led to the conclusion that PSP/reg may be a protein involved in regeneration (7) and furthermore may act as a growth mediator stimulating the proliferation of beta -cells. Tissue culture studies implied a mitogenic activity of PSP/reg on the growth of various cell types (8, 9), and application of PSP/reg was observed to partially ameliorate diabetes in NOD mice (10). Recently, a receptor was cloned from regenerating islets that binds PSP/reg and causes an increase in proliferation of cells transfected with a vector containing the receptor cDNA (11). Reg II (PAP I) appears to be involved in regeneration of motor neurons by acting as a Schwann cell mitogen (12).

Still other investigations sought to implicate PSP/reg in the digestive process. However, recent studies did not show regulated PSP/reg synthesis and secretion in response to changes in nutritional substrates in the diet (13).

Pancreatitis-associated protein (PAP) is a 16-kDa basic protein with an isoelectric point in the range of pH 6.5-7.6. Although most species contain a single PAP form, rat contains three isoforms, PAP I, PAP II, and PAP III, transcribed from three separate genes (14-16). PAP levels increase in pancreatic juice during experimental (17) and clinical (18) pancreatitis. Although showing an acute phase response under conditions of pancreatic disease, the function of PAP remains unknown.

PSP/reg and PAP forms, cloned in the rat, mouse, cow, and man, show similarities in amino acid sequence. At the C terminus there is a C-type lectin binding sequence, and it has been proposed that this site might confer bacterial resistance on PAP (14, 19). Recent studies have demonstrated that PSP/reg and PAP both act as acute phase reactants in pancreatic juice under a variety of conditions including acute pancreatitis (20), chronic pancreatitis in male WBN/Kob rats, and during the post-weaning period (21). Trypsin cleavage of PSP/reg and PAP has resulted in the appearance of precipitated proteins believed to represent insoluble thread structures in humans (22) and cows (23). However, it remains difficult to understand how precipitation properties could serve useful functions in pancreatic physiology, and it is not clearly known whether these precipitated protein forms demonstrate specific or nonspecific structures.

By taking a different approach in this study, we have attempted to define the functional as well as structural similarities shared between these molecules as a means to generate clues related to their function. To this end we have cloned, expressed, and purified recombinant forms of PSP/reg, PAP I, PAP II, and PAP III in the rat (24, 25). These purified reagents have allowed us to investigate the structural and functional properties of these proteins before and after trypsin cleavage to search for a unifying hypothesis that might explain the function of these proteins in pancreatic physiology and pathology.

In this paper we have studied the structural/functional consequences of trypsin activation on these proteins with respect to (i) resistance of the processed forms to trypsin as well as to the heterogeneous mixture of proteases in pancreatic juice, (ii) the kinetics of conversion from soluble to insoluble protein forms, (iii) the kinetics of assembly of protein subunits into polymerized thread structures, and (iv) the morphology of polymerized thread structures by scanning, transmission scanning, and transmission electron microscopy.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Recombinant PSP/reg-- Recombinant PSP/reg was produced in the baculovirus system and purified as described previously (3, 24). Monospecific antibodies directed against rat PSP/reg were generated in rabbits as described earlier (24).

Construction of Recombinant PAP Isoforms in Pichia pastoris Vectors-- PAP I cDNA and PAP II cDNA were amplified using the polymerase chain reaction (PCR) from a rat pancreas cDNA library using PAP I- and II-specific primers and confirmed by DNA sequencing. PAP III cDNA was isolated by reverse transcriptase-PCR using rat ileum mRNA as a template. First, total RNA was extracted from rat ileum as described (13), and then mRNA was prepared with an Oligotex mRNA minikit (Qiagen). Reverse transcription of 5 µg of ileal mRNA was performed in a volume of 25 µl at 37 °C for 30 min using 19 units of Moloney murine leukemia virus-reverse transcriptase (Amersham Pharmacia Biotech) and a PAP III-specific primer.

All three PAP isoforms are secretory proteins; therefore, we attempted to direct the accumulation of recombinant proteins in the media rather than intracellularly. To ensure that these proteins are secreted by P. pastoris, the endogenous PAP signal peptides were substituted by the signal peptide of the alpha -mating factor. The latter contains a Kex2 signal cleavage site consisting of a Lys-Arg followed by a Glu. Since all PAP isoforms start with a Glu, the PCR and subcloning strategy was designed to produce a cDNA with the Lys-Arg site followed by the first amino acid of the PAP isoforms (Glu). At the 5'-end of the cDNAs an XhoI site was included that facilitates ligation of the cDNA with the pBlueScript and recreates the correct reading frame of the alpha -mating factor signal peptide in pPIC9 (viz. manual of the Pichia Expression Kit, Invitrogen).

The cDNAs were processed using a two-step PCR amplification procedure. In a first PCR, an antisense primer was combined with the matching sense primer (all primer sequences are described in Ref. 25). Second, the purified PCR products were combined in another PCR with the same antisense primers and a set of sense primers causing an elongation of the cDNA. PCR was performed on a PerkinElmer Life Sciences Gene Amp PCR system 9600 using Taq DNA polymerase (Amersham Pharmacia Biotech). 30 cycles were run (1 min at 94 °C, 2 min at 55 °C, and 3 min at 72 °C). After each amplification step the cDNAs were purified by excising them from agarose gels (26). The recovered cDNAs were purified by phenol extraction and sodium acetate/ethanol precipitation.

The cDNAs were subsequently digested with XhoI and EcoRI restriction endonucleases (Amersham Pharmacia Biotech). The digests were purified and subcloned into pBlueScript (Stratagene) using T4 ligase (Amersham Pharmacia Biotech). TOP F10' Escherichia coli cells were transformed with the ligated plasmids by electroporation using a Bio-Rad Pulser II. Purified plasmids from individual colonies were digested with restriction enzymes to check for inserts, and some were subsequently sequenced to confirm the correct orientation of the coding sequence. Plasmids carrying the correct sequence were then digested with XhoI and EcoRI restriction enzymes, and the inserts were subcloned into the Pichia shuttle vector pPIC9 (Invitrogen). One recombinant vector for each isoform was sequenced again to confirm the correct insertion and sequence.

Transformation and Selection of High Expression Clones-- The Pichia strains GS115 and KM71 (Invitrogen) were transformed with the linearized recombinant pPIC9 vector (SalI restriction endonuclease) by electroporation according to the supplier's recommendations. The transformants were plated on histidine-deficient minimal dextrose (MD) agar plates (1.34% yeast nitrogen base, 0.00004% biotin and 1% dextrose), and colonies were analyzed for insert integration by PCR, using the alpha -factor primer and the 3' AOX1 (alcohol oxidase) primer. Positive clones were selected and tested with respect to their expression levels. By using a shaking incubator at 280 rpm, colonies were grown at 29 °C in baffeled flasks, each containing 80 ml of buffered minimal glycerol (BMG) medium (100 mM potassium phosphate, pH 6.0, 1.34% yeast nitrogen base, 0.00004% biotin, and 1% glycerol). Culture growth was monitored by measurement of the absorbance (600 nm); when an A600 between 2 and 6 was reached, the cells were harvested by centrifugation. To induce expression of the recombinant protein, the cells were resuspended in 12 ml of BMM medium (BMG medium, containing 0.5% methanol instead of glycerol) and cultured for 6 days. The protein secretion was monitored in 24-h intervals by electrophoretic analysis of the supernatant (Coomassie-stained SDS-15% polyacrylamide gels). The most productive clones were selected and cultured in increased culture volumes. The highest yields were found in 5-day-old cultures.

Purification and Analysis of Recombinant Proteins-- High yield media were collected by centrifugation at 1500 × g for 5 min at 4 °C. The supernatants were centrifuged again at 5000 × g for 15 min. The supernatants were diluted 1:3 with chilled MilliQ filtered water (Millipore) and adjusted to pH 3.6 with HCl. Diluted protein solution (1200-1600 ml) was applied at a rate of 5 ml/min to a cation exchange column (SP-Sepharose, Amersham Pharmacia Biotech, 26 × 80 mm) with a bed volume of 40 ml. The column was washed with 2 volumes of starting buffer (50 mM MES, 10 mM LiCl, pH 5.3). The proteins were eluted with a linear LiCl gradient (0-35% elution buffer: 50 mM MES, 2 M LiCl, pH 6.3), generated by an AKTA purifier system (Amersham Pharmacia Biotech).

Analysis of Purified Recombinant Proteins by Mass Spectrometry and N-terminal Sequencing-- To verify the identity of each of the isoforms, both mass spectrometry (electrospray mass analysis, PerkinElmer Life Sciences) and N-terminal amino acid sequencing was performed. The secreted, purified forms of PAP I, II, and III were desalted by ultrafiltration. To identify the new N terminus of the trypsin-resistant 14-kDa protein, each isoform was digested with trypsin as described below. The solutions were centrifuged to pellet the fibrils and remove the cleaved undecapeptide. For PAP II, the solution was filtered after digestion with an ultrafiltration device that retained the C-terminal peptide (10-kDa molecular weight cut-off, Centricon, Millipore). For mass analysis, aliquots were adsorbed to C18 ZIP tips (Millipore), eluted with 78% methanol, 1% formic acid, and injected into the analyzer.

Production of Antisera against PAP-- One hundred micrograms of recombinant PAP II were injected in Freund's complete adjuvant into several subcutaneous deposits in the back of a New Zealand White rabbit and a guinea pig. After 1 month the animals were boosted with 50 µg of PAP II in Freund's incomplete adjuvant followed by a similar boost a month later. Antibody titers were monitored in serum after venopuncture of the ear vein. Terminal bleeding was performed under anesthesia (Ketamine/Xylazine) by heart puncture. The antibody directed against PAP II reacts with PAP II (100%), PAP III (35%), PAP I (<10%), PATP II (80%), PATP III (<10%), and PATP I (<10%) but does not react with PSP/reg.

Activation of Pancreatic Juice-- Twenty microliters of rat pancreatic juice were diluted in 400 µl of Tris-Calcium buffer (10 mM, pH 8.0, 1 mM CaCl2) and equilibrated at 37 °C. An aliquot was withdrawn, and enteropeptidase (Worthington) was added at a final concentration of 0.1 unit/ml. The reaction was continued at 37 °C for 16 h during which several aliquots were withdrawn as a function of time as indicated in Fig. 1. The aliquots were transferred into a tube containing 50 µg of FOY 305, a potent trypsin inhibitor, and snap-frozen in liquid nitrogen until all aliquots had been collected. The samples were then rapidly thawed and centrifuged at 10,000 × g for 10 min in a cooled Beckman centrifuge (TL-100). The supernatant fraction was transferred to a new tube, and the pellet fraction was washed with 50 µl of Tris-Calcium buffer and centrifuged as described above. The pellets were dissolved in Tris-Calcium buffer in the original volume of the sample. They were prepared for electrophoresis by adding a 0.5 volume of 3-fold concentrated SDS-sample buffer (150 mM Tris-HCl, pH 6.8, 3% SDS, 0.015% bromphenol blue, 15% glycerol v/v) followed by heating for 5 min at 90 °C. To maximize immunoreactivity of the activated protein forms, beta -mercaptoethanol was omitted from the buffer solutions.

Tryptic Activation of PAP, PSP/reg, and Pancreatic Juice for Morphological Analysis-- Activation of the recombinant proteins was performed in a volume of 100 or 200 µl in Tris-Calcium buffer. Proteins (10 or 20 µg) were activated with 0.5-1 µg of trypsin (Worthington) for 30 min at 37 °C.

SDS-PAGE and Western Blotting-- Standard 15% polyacrylamide gels were prepared in SDS. Protein samples were heat-denatured at 90 °C in SDS-sample buffer (50 mM Tris-HCl, pH 6.8, 1% SDS, 0.005% bromphenol blue, and 5% glycerol) in the presence or absence of beta -mercaptoethanol as indicated above. Proteins resolved in gels were stained with Coomassie Brilliant Blue (0.1% in 30% methanol, 10% acetic acid, Bio-Rad). For Western blot analysis, the proteins were transferred to polyvinylidene difluoride membranes (Bio-Rad) (24) on a semidry blotting apparatus (Amersham Pharmacia Biotech). The membranes were blocked with 1% bovine serum albumin in Tris-buffered saline (20 mM Tris, pH 7.5, 150 mM NaCl). Guinea pig anti-PAP II, diluted 1:3000 (25), and phosphatase-coupled anti-guinea pig IgG, diluted 1:10,000 (Sigma), were used to detect PAP and PATP. For the detection of PSP/reg and PTP, chemiluminescence (ECLplus, Amersham Pharmacia Biotech) was employed. The primary rabbit anti-PSP/reg antibody was diluted 1:20,000 in Tris-buffered saline containing 1% bovine serum albumin. The membranes were washed in Tris-buffered saline containing 0.05% Tween 20. The secondary antibody, peroxidase-coupled goat anti-rabbit IgG (Sigma) was diluted 1:25,000 in the same buffer. Development and detection followed the manufacturer's recommendations.

Densitometry-- Relative quantities of individual protein bands were estimated by densitometry. Coomassie Blue-stained gels or Western blots were scanned with a Scanjet 6300C (Hewlett-Packard). The files were imported into Adobe Photoshop and quantified using ImageQuant (Molecular Dynamics) software. Intensities were expressed in percent of the maximal value as indicated in the figure legends.

Differential Centrifugation of Thread Proteins-- Recombinant thread proteins were diluted to 10 µg/50 µl in Tris-Calcium buffer and centrifuged in Microfuge tubes (Beckman) using a table top ultracentrifuge (Beckman TL 100). Following centrifugation of the sample at 1000 × g (4 °C, 30 min), the supernatant fractions were transferred to new tubes and centrifuged at 10,000 × g for 30 min at 4 °C. The resulting supernatant fractions were centrifuged at 100,000 × g for 30 min at 4 °C. The pellets were washed with Tris-Calcium buffer (described above) and redissolved in the original volume. Pellet and supernatant fractions were denatured in the presence of SDS-sample buffer, including 1% beta -mercaptoethanol, for 5 min at 90 °C and submitted to SDS-PAGE.

Analysis of Protein Matrices by Scanning Electron Microscopy (SEM)-- For scanning electron microscopy, pouches of nylon mesh, ~1 cm2, were produced by folding a small piece of nylon mesh. The edges were heat-sealed, except for a small hole through which the samples could be introduced. The activation mixtures were transferred into the pouch, closed with a clamp, and submerged in 50 mM sodium cacodylate, pH 7.5, for 30 min at 4 °C. The pouch was then transferred to 2% glutaraldehyde in 100 mM sodium cacodylate, pH 7.5. After fixation at 4 °C overnight, the pouches were opened and processed for SEM analysis using standard procedures. The samples were viewed on a JEOL (JSM-25S II) scanning electron microscope. Photographs were taken via an attached computer using the software DISS (Digital Image Scanning System, Prophysics, Switzerland).

For scanning transmission electron microscopy (STEM, Philips CM 120) analysis, a small amount of fibrillar material was removed from the surface of the pouch and plated with gold. To exclude gold-derived artifacts, the following pilot study was performed. After glutaraldehyde fixation, the pouch (see above) was immersed in 2% OsO4, 0.1 M sodium cacodylate buffer for 3 h. The pouch was rinsed and processed for SEM and STEM. In the absence of gold plating, the quality of resolution of the protein matrix was inferior compared with the gold-plated sample. However, it was concluded that the structure of the unplated sample was comparable to the structure of the gold-plated sample.

Analysis of Protein Matrices by Transmission Electron Microscopy-- To prepare thin sections of fibrils for examination in the electron microscope, the activation mixtures were initially embedded in Epon. However, this approach required extensive centrifugation after each medium change and a polymerization step at 60 °C. The resulting preparations appeared amorphous due to the loss of the fibrillar architecture. To circumvent this problem, we omitted centrifugation and used an alternative procedure that did not require polymerization at 60 °C. The digests were mixed with 0.1 volume of 25% glutaraldehyde and left at 4 °C overnight. Then OsO4 was added to a final concentration of 2 mM, and fixation was continued at room temperature for another hour. The fibrils demonstrated a black appearance and settled to the bottom of the vessel. Unicryl (British Biocell Int., Cardiff, UK), an embedding medium that polymerizes at low temperatures under UV light, was used according to the manufacturer's recommendation. Thin sections were cut with a diamond knife and examined in an electron microscope (Philips 400). As a negative control for this procedure, buffer was substituted for the activation mixture and processed as described above. Although some amorphous material was generated during OsO4 fixation, the fibrillar structures were not observed in the control.

For negative contrast staining of fibrils, a small drop of activated sample was placed on the surface of a grid, dried, exposed to phosphotungstic acid (27), and examined in the electron microscope.

Computer Programs for Sequence Analysis-- The multiple sequence alignment was created by "PileUp," an algorithm for progressive, pairwise sequence alignments by Feng and Doolittle (28). The same program produces a dendrogram that depicts the clustering relationships. The determination of sequence similarity and identity was performed by pairwise analysis using the program "Gap." Gap and PileUp are part of the Wisconsin package version 9, supplied by Genetics Computer Group (Madison, WI). GCG is run on a UNIX system (Silicon Graphics) maintained by the Rechenzentrum der Universität Zürich.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Conservation of the N-terminal and C-terminal Peptides in a Family of 16-kDa Secretory Proteins-- Fig. 1 shows the sequence alignment of the N-terminal and C-terminal regions of three isoforms of PAP with PSP/reg in the rat. The mature secretory proteins are defined by two peptide domains separated by a highly conserved trypsin cleavage site. In three of the four secretory stress proteins (PSP/reg, PAP I, and PAP III), the Arg11-Ile12 bond represents the most sensitive cleavage site for trypsin. Upon trypsin cleavage the N-terminal undecapeptide is separated from the C-terminal peptide, which varies from 138 residues in PAP to 133 residues in PSP/reg.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   Conservation of the N-terminal trypsin cleavage site in a family of secretory stress proteins. The amino acid sequences of the mature (secreted) rat proteins PSP/reg, PAP I, II, and III were aligned. The N termini of the four sequences each contain a propeptide (Pro, solid line) of 11 amino acids ending with the highly conserved trypsin cleavage site (Try). This cleavage site is conserved in 16 PSP/reg-related proteins from 6 different species (human, bovine, pig, rat, mouse, and hamster). All but one of the activation peptides contain 11 amino acid residues. Position 12 marks the N termini of the activated proteins (dashed line). The complete sequence of the stress proteins is 144 (PSP) to 149 (PAP isoforms) amino acids in length. The position of the putative cleavage sites for the 15-kDa intermediate PAP isoforms (lysines underlined) is marked at the top (). The C-terminal alignment, separated by two dots, includes the C-type lectin domain signature (underlined residues).

In addition to similarities in size, these proteins show similarities in sequence and protein domains. PSP/reg shows 43% identity and 54% similarity with PAP I, 45% identity and 52% similarity with PAP II, and 50% identity and 57% similarity with PAP III. PSP/reg is five amino acids shorter than the three PAP isoforms. The conservation of six cysteine residues suggests that three disulfide bonds are conserved. At the C terminus there is a conserved sequence indicating a C-type lectin domain (Fig. 1). Although the function of this signature sequence has not been elucidated, CTLs have been found in a variety of proteins that demonstrate diverse functions in different cellular and extracellular compartments (29). However, the conserved N-terminal trypsin cleavage site is not observed in other proteins bearing CTLs.

The secreted and proteolytic processed forms of recombinant PSP/reg and recombinant PAP shown in Fig. 1 were analyzed by mass spectrometry and N-terminal sequencing. The secreted forms of PAP I, II, and III all conformed with the expected amino acid sequence (first 10 amino acids determined), starting with a glutamine residue in each case. The processed forms of PAP also conformed with the expected sequence (first 5-7 amino acids determined) starting with an isoleucine (PATP I, III) or a threonine (PATP II) residue. Mass analysis yielded the following measurements: PAP I, 16623.6 (theoretical 16623.6); PATP I, 15414.0 (15414.2); PAP II, 16404.2 (16403.2); PATP II, 15203.9 (15203.9); PAP III, 16247.8 (16248.0); and PATP III, 15021.5 (15019.7). Mass determinations indicated that PSP/reg and each of the PAP isoforms were not modified by glycosylation or other posttranslational mechanisms.

Trypsin Activation of Rat Pancreatic Juice Generates Protease-resistant Products with Low Solubility-- By utilizing purified recombinant PSP/reg and PAP III, we have recently demonstrated that trypsin activation leads to the formation of 14-kDa trypsin-resistant products (25). In order to determine if the 14-kDa products are resistant to the wide spectrum of proteases observed in activated pancreatic juice, we studied the identity and longevity of these products generated from rat pancreatic juice containing high levels of PSP/reg (320 µg/ml) and PAP (116 µg/ml). Fig. 2 shows the Coomassie Blue and immunostained products that appear in soluble and insoluble fractions of pancreatic juice, diluted into 20 volumes of buffer and activated with enterokinase at 37 °C, over a period of 960 min (16 h).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   Trypsin activation of pancreatic juice generates 14-kDa products that are protease-resistant and sediment under conditions of low speed centrifugation. Pure pancreatic juice from a rat with high levels of PSP/reg and PAP was activated with enteropeptidase. Aliquots were withdrawn at the indicated time points (min), and reactions were stopped by the addition of FOY-305, a protease inhibitor. The samples were centrifuged, and the supernatant fractions were transferred to a fresh tube. The pellet (P) and supernatant (S) fractions were analyzed separately by SDS-polyacrylamide gel electrophoresis. The top panel of the figure shows the Coomassie Blue-stained gel. M, marker proteins with the sizes indicated in kDa. The middle panel (PSP) shows an immunoblot of the same gel analyzed for the proteolytic conversion of PSP/reg to PTP (arrowheads indicate their position). The bottom panel shows an immunoblot analyzed for the proteolytic conversion of PAP to PATP (arrowheads).

At the beginning of the experiment (0-, 0.5-, and 1.0-min time points), the major digestive enzymes and zymogens present in pancreatic juice may be easily identified (30, 31). These include amylase (major band at 55 kDa), procarboxypeptidase A and B isoforms at 40-45 kDa, and serine protease zymogens between 21 and 27 kDa. At later time points these bands disappear in response to the degradative effects of activated proteases. Despite the progressive degradation of the digestive enzymes and zymogens, a prominent Coomassie Blue-stained band appears at 14 kDa in the pellet fraction at 10 min and remains largely intact throughout the duration of the experiment.

In order to determine the composition of this 14-kDa protease-resistant band, we used polyclonal antibodies individually directed against PSP/reg and PAP to determine the representation and longevity of PTP and PATP isoforms in this region of the gel. The antibody directed against PSP recognizes both PSP and PTP. The antibody directed against PAP II reacts with PAP II (100%), PAP III (35%), PAP I (<10%), PATP II (80%), PATP III (<10%), and PATP I (<10%) but does not react with PSP/reg.

Between 1 and 10 min PSP/reg disappears from the supernatant fraction, and PTP appears in the pellet fraction. However, PTP appears in the supernatant fraction before it appears in the pellet fraction, suggesting that soluble PTP requires time to polymerize into insoluble PTP complexes. Similar findings are observed in the conversion of PAP to PATP, with two exceptions. First, whereas conversion of PSP/reg occurs between 1 and 10 min, the conversion of PAP occurs more slowly, largely between 10 and 60 min. Second, the PAP/PATP signal is less intense, due to the lower concentration of PAP isoforms and possibly compounded by a lower binding of the antibody to its target protein(s).

These findings indicate that trypsin activation leads to the rapid conversion of PSP/reg and PAP forms to trypsin- and protease-resistant forms of PTP and PATP, respectively. The longevity of PTP and PATP forms in the presence of fully activated pancreatic juice containing numerous protease forms is impressive and suggests that the two groups of thread proteins have evolved with similar properties of protease resistance that may be related to the ultimate function of these proteins in pancreatic physiology and pathology.

To gain more insight into the temporal aspects of activation and polymerization of thread proteins, the gels and blots were analyzed by densitometry. Fig. 3A shows the relative abundance of Coomassie Blue-stained products in the pellet fraction as a function of time. Fig. 3B shows the kinetic data for conversion of PSP/reg to PTP as well as the conversion of PTP from a soluble form to an insoluble form. The data demonstrate that proteolysis precedes the polymerization process by several minutes and identifies an intermediate state between soluble precursor and insoluble product. Furthermore, the data suggest that PTP occurs in a soluble form before its polymerization into insoluble thread structures. Fig. 3C shows kinetic data for the conversion of PAP to PATP and similarly identifies an intermediate state represented by soluble PATP prior to its polymerization into insoluble thread structures.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Kinetics of tryptic conversion of secretory stress proteins to soluble and insoluble thread proteins in pancreatic juice. The gel and immunoblots shown in Fig. 2 were analyzed by densitometry and plotted as a function of time. A, relative abundance of Coomassie Blue-stained 14-kDa bands (CBB) in the pellet fraction (black-down-triangle ) at each time point. Maximum density was arbitrarily set at 100%. B, relative abundance of PSP/reg () and PTP in the soluble (black-square) and PTP in the insoluble (black-diamond ) fractions. The sum of soluble and insoluble PTP at 10 min was set as 100%. C, PAP () and PATP (black-square) in the soluble and PATP in the insoluble (black-diamond ) fractions were determined from the PAP immunoblot as described for B. The PAP value at 1 min was set at 100%; for PATP, the combined soluble and insoluble fraction at 10 min was set as 100%. Note that the antibodies do not recognize the unprocessed and processed forms with equal sensitivity. The 15-kDa band (see Fig. 4) was not quantified. Similar activation kinetics were observed for trypsin-activated pancreatic juice.

In the presence of fully activated pancreatic juice at 37 °C the half-life is 100-150 min for the PATP band, 800 min for the PTP band, and 400 min for the Coomassie Blue band. Thus, the activation of secretory stress proteins into insoluble thread proteins leads to strong resistance to the degradative effects of pancreatic proteases.

Kinetics of Proteolytic Conversion of Recombinant PAP Isoforms and Assembly of Products into Insoluble Thread Complexes-- Because our PAP antibody could not track individual PAP/PATP forms and furthermore recognized PAP II with greater affinity than PAP I or PAP III, we studied the conversion of purified recombinant PAP forms to PATP forms under three conditions as follows: (i) trypsin activation, (ii) activation in the presence of enteropeptidase-treated pancreatic juice, and (iii) trypsin activation followed by the addition of pancreatic juice after the formation of protein fibrils. Fig. 4 shows the results of trypsin activation on PAP I, PAP II, and PAP III and monitors proteolytic processing to smaller thread proteins in soluble and insoluble fractions. These kinetic studies demonstrate that PAP I and PAP III isoforms are rapidly, i.e. within 1 min, cleaved from 16-kDa precursors to 14-kDa products. 14-kDa products initially appear as soluble intermediate products but rapidly polymerize into insoluble sedimenting structures. The 50% threshold for formation of insoluble products was 3 and 0.8 min for PATP I and PATP III (Fig. 4, A and C), respectively. In contrast, although PAP II was rapidly processed to 15- and 14-kDa forms by trypsin (PAP II contains an additional trypsin cleavage site at Lys5-Ala6), these products remained soluble throughout the duration of the 16-h incubation period.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 4.   Kinetics of tryptic conversion of recombinant PAP isoforms to soluble and insoluble thread proteins. Top panels, Coomassie Blue-stained gels of PAP I, II, and III activated with trypsin. Samples were obtained at the indicated times (min) and separated into pellet (P) and supernatant (S) fractions by centrifugation at 10,000 × g for 10 min at 4 °C. Molecular weight markers on the left at 14 and 18 kDa. Bottom panels, densitometric analysis of these gels is shown in A (PAP I), B (PAP II), and C (PAP III) as a function of time through 960 min and monitors 16-kDa soluble precursors (), soluble intermediate products at 15 kDa (black-triangle), and 14 kDa (black-square) soluble and insoluble sedimenting products (black-diamond ). D (PAP I), E (PAP II), and F (PAP III) show bar graphs indicating the percent survival of PATP isoforms after 16 h of incubation. PAP was incubated with trypsin (stippled bar); PAP isoforms were added to pancreatic juice activated by enteropeptidase (lightly hatched bar), and PATP (trypsin activated) was added to pancreatic juice activated by enteropeptidase (darkly hatched bar). PATPs survival in pancreatic juice (with low levels of PSP/reg and PAP) are taken from a separate set of experiments.

During proteolytic processing intermediate sized peptides (15 kDa) appeared transiently in the incubation mixtures containing PAP isoforms. The intermediates are consistent with proteolytic processing at lysine residues contained within the N-terminal undecapeptide (cf. Fig. 1). These intermediate forms are most prominent in the case of PAP II, which demonstrates an Arg-Thr trypsin cleavage site. This finding is consistent with Arg-Iso being a more active trypsin cleavage site than Arg-Thr, which is observed in PAP isoforms I and III.

Fig. 4, D-F, shows the survival of PATP isoforms after 16 h of incubation in the presence of (i) trypsin, (ii) activated pancreatic, and (iii) trypsin-activated PAP followed by addition of activated pancreatic juice (with low endogenous PSP/reg and PAP levels). These studies demonstrate that PATP I and PATP III isoforms show complete resistance to trypsin and partial resistance to the mixture of proteases contained in pancreatic juice. These proteases include serine proteases (trypsin, chymotrypsin, and elastase) and metalloproteinases (carboxypeptidases A and B). Thread proteins exposed to pancreatic proteases, after fibril formation had been completed, appeared to show greater resistance to pancreatic proteases (45 and 54% survival after 16 h of incubation for PATP I and PATP III, respectively) than those formed in the presence of pancreatic proteases (4 and 27% survival after 16 h of incubation for PATP I and PATP III, respectively). PATP III showed greater resistance to pancreatic proteases than PATP I. In contrast, although PATP II showed trypsin resistance, it was completely digested within 60 min of addition of activated pancreatic juice.

Secretory Thread Proteins Show Differential Sedimentation Properties-- In order to compare the physical properties of insoluble thread proteins, we activated purified recombinant forms of PSP/reg, PAP I, PAP II, and PAP III. Trypsin cleavage converted these recombinant forms into PTP, PATP I, II, and III, respectively. In previous studies we had observed that PTP, PATP I, and PATP III sediment under conditions of centrifugation at 10,000 × g for 10 min at 4 °C. In contrast, PATP II could not be sedimented under these conditions.

To explore in greater detail the sedimentation properties of these four activated proteins, we studied their sedimentation at varying conditions of centrifugation. Fig. 5A shows the results of sedimentation of trypsin-activated proteins (10 µg of protein/50 µl) at 1,000, 10,000, and 100,000 × g for 30 min at 4 °C. Pellet fractions from the three sedimentation conditions and the final supernatant fraction were submitted to SDS-PAGE for each of the recombinant forms.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Members of the family of secretory thread proteins show differential sedimentation. A, pancreatic thread proteins were centrifuged at increasing g force as follows: initially at 1,000 × g for 30 min at 4 °C, then the supernatant fractions were transferred and centrifuged at 10,000 × g for 30 min at 4 °C, and finally at 100,000 × g for 30 min at 4 °C. The supernatant and the pellet fractions were dissolved in sample buffer, and proteins were resolved by SDS-PAGE. The bands were analyzed by densitometry and expressed as percent of the total (pellet fractions plus the supernatant fraction). The top panel shows the section of the gel used for densitometric analysis. B, pH-independent solubility of PATP II. PAP II was digested with trypsin, acidified to pH 3, and neutralized by buffer exchange (AN). Aliquots were then mixed with buffers of various pH and centrifuged. Proteins in the pellet and supernatant were resolved by SDS-PAGE. M, markers at 14 and 18 kDa.

The data indicate that 67% of PATP I is sedimented at 10,000 × g, an additional 14% is sedimented at 100,000 × g, and 11% remains in the final supernatant fraction. Under these conditions PATP III shows greater insolubility with 87% sedimented at 10,000 × g and minimal amounts observed in the 100,000 × g fraction and the final supernatant fraction. PTP appears to sediment over a wider range of g forces, demonstrating 25% in the 1,000 × g fraction, 52% in the 10,000 × g fraction, 23% in the 100,000 × g fraction, and negligible amounts in the final supernatant fraction. In contrast, PATP II appears to be largely soluble under these conditions: 14% sedimented up to 100,000 × g and 86% was observed in the final supernatant fraction.

In order to investigate whether PATP II enters into insoluble aggregates at acidic or alkaline pH, we suspended trypsin-cleaved PATP II at different pH values, and we monitored aggregation with SDS-PAGE after centrifugation at 10,000 × g for 10 min. Fig. 5B demonstrates the absence of sedimenting complexes at all pH values tested under these conditions.

These data confirm the insoluble nature of PTP, PATP I, and PATP III and the soluble nature of PATP II. Questions now arise whether these insoluble complexes are specific or nonspecific and whether they serve functions important in pancreatic physiology.

Trypsin Activation of Purified Recombinant Secretory Stress Proteins Generate Matrices of Highly Organized Fibrils-- To characterize the morphological structures of the insoluble thread proteins (PTP, PATP I, and PATP III), the recombinant precursors were activated with trypsin and analyzed by a variety of electron microscopy methods. Previous studies that attempted to elucidate the structures of PTP-derived fibrils were hampered by fibril fragmentation and the collapse of fibrils when they were placed onto a surface and dried down. Collapse of fibrils resulted in a nonspecific amorphous appearance of the matrix complex without distinguishable markings.

To circumvent the collapse of the three-dimensional architecture, we constructed small pouches of nylon mesh, which were then filled with fibril-containing solutions. The pouch could then be transferred into the various washing and fixation solutions without the need for attachment to a glass support. Fig. 6 shows fibrils generated in this manner and examined in the scanning electron microscope. With the exception of PATP II, which did not form visible fibrils, all other forms produced a matrix of highly organized fibrils.


View larger version (119K):
[in this window]
[in a new window]
 
Fig. 6.   Trypsin activation of purified recombinant secretory stress proteins generates a matrix of highly organized fibrils. Scanning electron microscopy of PTP and PATP generated in vitro. The micrographs demonstrate fibrous networks following activation of PAP I, PAP III and PSP/reg with trypsin. A and D show the matrix obtained with PATP I (A, bar 70 µm; D, 3 µm). B and E show the matrix obtained with PATP III (B, 20 µm; E, 7 µm). C and F show the matrix obtained with PTP (C, 40 µm; F, 4 µm). Inset in B gives a higher magnification micrograph showing individual fibrils that emerge from the dense matrix. A and C, part of the plastic mesh of the pouch can be seen.

Fig. 6 shows scanning electron micrographs of matrices formed from PATP I (A and D), PATP III (B and E), and PTP (C and F). Low power micrographs (A-C) indicate the appearance of tight matrices covering the nylon mesh in the pouch. Matrices appear to attach to the nylon mesh. At higher power differences were observed in matrices formed from activation of the three recombinant proteins. PATP I (D) shows tight bundling of filaments into larger diameter fibers that contribute to the meshwork. PATP III (E) shows loose bundling of filaments in a nodular distribution particularly near the edges. PTP (F) shows more delicate filaments comprising the meshwork and less bundling. The inset in Fig. 5B shows that individual fibrils appear to "grow out" of the densely polymerized matrix. Extensive branching appears in each of the observed matrices.

These studies demonstrate that insoluble thread proteins form dense, highly organized three-dimensional matrices. Through bundling, branching, and extension processes, these fibrillar threads achieve higher ordered matrix structures that span large topological surfaces.

High Resolution Analysis of Fibrillar Structures Using Transmission Electron Microscopy and Scanning Transmission Electron Microscopy-- In order to determine the fine structure of individual filaments, we examined the morphological appearance of matrices using a variety of techniques that employ transmission EM and scanning transmission EM (Fig. 7, A-E).


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 7.   High resolution structural analysis of activated secretory stress proteins by transmission electron microscopy. A, scanning transmission electron micrograph of the PTP matrix (bar, 100 nm). B and C, negative staining of PTP (B) and PATP III (C), original magnification × 71,000, bar 200 nm; D and E, thin section of PTP (D) and PATP III (E) matrix embedded in low temperature Unicryl (original magnification × 180,000, bar 70 nm). Structural analysis by each of these methods indicate filamentous structures with diameters approximating 20 nm. High resolution analysis of PATP III in D and E suggests that protein subunits are organized in helical configurations. Favorable sections in this panel suggest the presence of cavities within these filamentous structures (arrowheads).

In Fig. 7A, a PTP matrix analyzed by scanning transmission electron microscopy is shown to examine the surface and branching properties. To exclude artifacts caused by gold plating, we explored whether the size and surface features of filaments were altered by gold spraying methods. Osmium-fixed samples were examined (i) without prior gold treatment, (ii) with lightly sprayed gold treatment (shown in A), and (iii) with the standard gold treatment. The morphology of the filaments showed little or no change as a function of gold treatment. However, the visualization of the filaments was improved with gold spraying.

Fig. 7, B (PTP) and C (PATP III), shows filaments that were negatively stained with phosphotungstic acid. This procedure, which causes extensive fragmentation of filaments, compares favorably with negatively stained micrographs that appear in the literature (22, 23).

To examine the higher ordered structure of polymerized thread proteins, fibrils were fixed in glutaraldehyde and osmium, embedded in low temperature Unicryl, sectioned, and examined with transmission EM. Under these conditions filaments (Fig. 7, D, PTP, and E, PATP III) appeared to be composed of subunits assembled into helical fibrillar structures. Favorable sections in this micrograph also suggested the presence of cavities within PATP III filamentous structures.

The data indicate that, regardless of the method employed or the protein species examined (PTP, PATP I, and PATP III), filaments exhibit a consistent diameter of ~15-20 nm.

Morphological Structure of Filaments and Matrices Generated from Activated Pancreatic Juice-- In order to determine if matrices and filaments formed from pancreatic juice mimic those observed from activated recombinant stress proteins, we activated rat pancreatic juice and prepared it for examination by scanning EM using the nylon pouch method described above.

We chose samples of pancreatic juice obtained from male WBN/Kob rats, which contain high levels of PSP/reg (150 µg/ml) and PAP (50 µg/ml) and spontaneously develop chronic pancreatitis. Fig. 8, A and C, shows low power and high power micrographs, respectively, of matrices generated by trypsin activation of juice from these animals. The morphological appearance of the filaments and three-dimensional architecture of the matrix appear to be intermediate between those observed for pure PTP and pure PATP I in Fig. 6.


View larger version (177K):
[in this window]
[in a new window]
 
Fig. 8.   Trypsin activation of 14-kDa proteins in pancreatic juice generates a matrix of highly organized fibrils. Pancreatic juice was incubated with trypsin and then transferred to a plastic pouch for fixation and drying. A and C, pancreatic juice from a WBN/Kob rat with high levels of PSP/reg (150 µg/ml) and PAP (50 µg/ml); bars 70 and 3 µm, respectively. B and D, fibrils generated in pancreatic juice from a Wistar rat with lower levels of PSP/reg (14 µg/ml) and very low levels of PAP (1.4 µg/ml); bars 70 and 3 µm, respectively. A much smaller area of the pouch was covered with fibrillar material when pancreatic juice from Wistar rats was activated, and these fibrils are decorated with protein droplets in contrast to the "pure" threads from the WBN/Kob rat.

Fig. 8, B and D, shows low power and high power micrographs, respectively, of matrices generated by trypsin activation of pancreatic juice from normal Wistar rats (PSP/reg, 14 µg/ml; PAP, 1.4 µg/ml). The morphological appearance of the filaments and three-dimensional architecture of the matrix appear to be intermediate between those observed for pure PTP and pure PATP III in Fig. 6. We also noted that the amount of matrix covering the nylon mesh pouch was considerably less in the sample shown in B than that of A and correlated with the levels of secretory stress proteins in the two pancreatic juice samples.

These data indicate conclusively that trypsin activation of pure pancreatic juice can generate insoluble matrices of filamentous thread proteins that have the capacity to attach to and cover large surface areas in a manner similar to that observed for matrices generated from purified recombinant secretory stress proteins.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

This study investigates a group of 16-kDa proteins present in rat pancreatic juice without known enzymatic or inhibitory function in the digestive process. In addition to the similarity in size between PSP/reg and PAP isoforms, a comparison of amino acid sequences reveals significant structural homologies, including conservation in the position of six cysteine residues, which implies the conservation of three disulfide bonds. The conserved structural features of PSP/reg and PAP, including the locations of tryptophan residues, suggest that the members of this group of secretory proteins demonstrate highly conserved three-dimensional structures.2 In the rat all three of the PAP genes and the PSP/reg gene colocalize to the same segment on chromosome 4 (32), observations that suggest a common ancestral gene. Taken together, the conserved structural features in this group of genes suggest that they form a gene family generated through gene duplication processes.

The structural similarities in these genes are augmented by functional homologies. First, each of these proteins is synthesized and secreted by pancreatic acinar cells. Second, their synthesis and secretion is increased in response to conditions of pancreatic stress as follows. During experimental acute pancreatitis, PAP (33, 34) is increased in pancreatic juice and PSP/reg mRNA is increased in pancreatic tissue (35). During chronic pancreatitis, both in man and in an animal model, the male WBN/Kob rat, PAP and PSP/reg levels are increased in pancreatic tissue (21, 36-38) and juice (21). During maximal caerulein stimulation and supramaximal caerulein-induced pancreatitis, PAP and PSP/reg levels are increased in pancreatic tissue (34) and juice.3 During the post-weaning period of pancreatic organ growth, PSP/reg levels are increased in pancreatic juice, and PAP levels show transient increases in tissue (39). During pancreatic regeneration following partial pancreatectomy, PSP/reg levels increase in pancreatic tissue (5, 40) (PAP levels have not been measured in this experimental protocol). The similarity in tissue response and secretion between PSP/reg and PAP isoforms under conditions of stress due to (i) post-weaning glandular growth including experimental pancreatic regeneration, (ii) hormone stimulation, and (iii) experimental and clinical disease suggests homologies of function for this family of proteins.

The wide divergence of proposed functions for this group of secretory proteins, summarized in the Introduction, suggests that the primary function of this gene family remains to be elucidated. In this study we have focused on an important structural feature, the conserved trypsin cleavage site (Arg11-Ile12 in PSP/reg, PAP I, and PAP III isoforms and Arg11-Thr12 in PAP II). This cleavage site is conserved in all proteins related to this gene family, both within a single species as well as across species lines. These proteins include human, rat, and mouse PSP/reg and PAP, bovine pancreatic thread protein, the trypsin cleavage product isolated from bovine pancreatic homogenates treated with trypsin, and PSP/reg protein isolated from pancreatic tissue in the hamster. This list may be extended to include islet neogenesis-associated protein (41) and islet neogenesis-associated protein-related protein (42). These proteins all share the C-type lectin binding domain, conserved amino acid sequences, including six cysteine residues, and a conserved trypsin cleavage site at the N terminus. In their unactivated state PSP/reg and PAP isoforms remain soluble during their secretory passage through the pancreatic duct and their delivery to the intestinal milieu. Cleavage at the conserved Arg11-Ile12 site leads to the removal of an N-terminal undecapeptide from the C-terminal polypeptide. This proteolytic processing feature has not been observed in any other proteins bearing a C-type lectin domain.

By using rat PSP/reg and PAP activated by trypsin, we have demonstrated in this study that the corresponding C-terminal peptides or thread proteins (pancreatic thread protein and pancreatitis-associated thread protein, respectively) remain largely resistant to proteases contained in pancreatic juice, including serine proteases (trypsin, chymotrypsin, and elastase) and metalloproteases (carboxypeptidases A and B). Despite the presence of numerous potential cleavage sites within their amino acid sequence, thread proteins show impressive protease resistance and survive the proteolytic degradation of the proteases themselves. Longstanding protease resistance implies that thread proteins undergo a significant change in conformational structure following activation and enter into tightly folded structures relatively impervious to the effects of exogenous proteases.

When pancreatic juice containing high levels of PSP/reg and PAP was activated, PTP and PATP survived through the 16-h time period (960 min). By utilizing antibodies to track the conversion of stress proteins to thread proteins, the half-lives of PATP forms and PTP were 100-150 and 800 min, respectively. Our recombinant studies indicated that PATP I and PATP III were entirely resistant to trypsin and substantially resistant to the mixture of pancreatic proteases after fibril formation. PATP III was resistant to pancreatic proteases both during and after fibril formation. In contrast, although PATP II was resistant to trypsin, it was completely degraded by pancreatic proteases within 60 min of adding pancreatic juice.

In these activation studies we also measured the kinetics of conversion of soluble intermediate proteins into insoluble sedimenting forms. These studies demonstrate that PTP, PATP I, and PATP III rapidly appear in the pellet fraction as insoluble thread proteins. The 50% threshold for conversion of soluble thread proteins to insoluble thread forms were 0.8, 3, and 5 min for PAP III, PTP, and PAP I, respectively. PATP II did not appear in an insoluble fraction. These findings suggest that, with the exception of PAP II, polymerization of soluble thread proteins (monomers) into insoluble forms (polymerized fibrils) is a specific assembly process that is dependent on time and protein concentration.

We have also studied the solubility characteristics of each of the rat pancreatic secretory thread proteins in detail and further confirmed that they fall into two groups. PATP I, PATP III, and PTP sediment at low speed centrifugation, whereas PATP II remains largely in the soluble fraction at either low speed or high speed centrifugation. Changes in incubation temperature had little effect on the physical characteristics of sedimentation for any of these isoforms. We conclude that PAP II is a nonsedimenting secretory stress protein.

Among pancreatic secretory stress proteins, PAP II shows a number of characteristics that distinguish it from the other forms, including (i) rapid digestion in the presence of pancreatic proteases, (ii) inability to polymerize into fibrils that may be isolated by low speed or high speed centrifugation, and (iii) undetectable fibrils analyzed by scanning and transmission electron microscopy. A dendrogram depicting the sequence relationship between PSP/reg and PAP isoforms of human, bovine, and rodent origin clearly demonstrates that PAP II is separated in a different evolutionary cluster distinct from either rodent PAP I and III isoforms or human PAP and bovine PAP. PAP II may serve as a facilitator or inhibitor in the coordinated assembly of insoluble thread structures during pancreatic stress reactions. Alternatively, PAP II may represent a nonfunctional secretory stress protein that has lost the critical sequences required for polymerization into fibrillar thread structures.

In humans and cows with chronic calcific pancreatitis, PTP has been identified as a major organic component of calcified stones. In both species thread proteins were isolated and shown to be fibrillar by negative staining in the electron microscope (22, 23). Purified PSP/lithostathine has been shown to form similar fibrils after tryptic cleavage in vitro (43), and prolonged incubation of PSP, purified by column chromatography, suggested that activation may occur by autoproteolysis. The studies reported here further extend the existence of fibrillar thread structures among pancreatic secretory proteins to include not only PTP but also PATP I and PATP III isoforms. This group of insoluble thread proteins appears to be generated from a family of pancreatic secretory stress proteins following trypsin activation.

The assembly of soluble thread proteins into insoluble fibrillar matrices by all of the 16-kDa proteins (PTP, PATP I, and PATP III), save one (PATP II), further substantiates the functional similarities in this family of secretory stress proteins. Analysis of the morphology of these fibrillar matrices by scanning and transmission electron microscopy, under a variety of staining and embedding methods, reveals highly organized structural features associated with extensively polymerized structures. Although features differ somewhat among individual thread matrices, there is a strong tendency for polymerized protein threads to bundle together. Bundling properties appear to be most developed (strong curvilinear bundles) in the case of PATP I filaments, less developed, and nodular, in the case of PATP III, and least developed (feathery matrix) in the case of PTP. Extensive branching of filaments in all three species leads to dense fibrillar matrices covering large topological surfaces.

High resolution analysis of fibrillar matrices by transmission EM suggests the presence of subunit structures apparently assembled into a helical fibrillar structure. Certain favorable sections point to the presence of a cavity within these filamentous structures. However, further structural studies will be required to determine the precise subunit structures of these filaments and the nature of cavities, should they exist. Our investigations to date with purified recombinant proteins have been confined to the assembly of homologous filaments. Polymerization of heterologous mixtures of thread proteins forms the basis for a separate study.

We have demonstrated that samples of pancreatic juice, upon trypsin activation, also form dense fibrillar matrices similar to those observed with purified recombinant proteins. Both normal pancreatic juice (Wistar rat), containing small concentrations of stress proteins (14 µg/ml PSP/reg and 1.4 µg/ml PAP), and pathological juice (male WBN/Kob rats), containing elevated concentrations of stress proteins (150 µg/ml PSP/reg and 50 µg/ml PAP), form dense fibrillar matrices. However, the extent of matrix formation appears to correlate with the amount of stress proteins observed in samples of juice.

Based on the findings presented here we propose that PSP/reg and PAP form a family of secretory stress proteins which, upon trypsin or "trypsin-like" activation, convert to a family of insoluble thread proteins. We further propose that the activated thread proteins represent the active form of these molecules whereas the secretory proforms represent inactive precursors. In order to begin to unify the terminology in this complex area, we suggest that PSP/reg may refer to "pancreatic stress protein" as well as "pancreatic stone protein."

Concerning their function, this family of secretory stress proteins may serve to form dense extracellular fibrillar complexes that attach to and span large topological surfaces during conditions of luminal stress. For example, these dense fibrillar structures may provide a luminal matrix from which the repair or regeneration of ductal structures may be orchestrated under conditions of stress. Since islet, acinar, and ductal cells are all derived from proliferating duct cells (44), it is possible that neogenesis of exocrine and endocrine tissue occurs as part of the more general process of ductal proliferation during pancreatic development or regeneration after partial surgical ablation of the gland. The mitogenic activity reported for PSP/reg (8) would be consistent with this notion. Further work is clearly needed to determine the role of luminal matrices during pancreatic development, growth, and repair and to determine the location of the activating enzyme, whether due to a soluble activity in pancreatic juice or a surface activator associated with ductal cells.

    ACKNOWLEDGEMENTS

We thank Drs. M. Höchli, R. Keller, H.-P. Gautschi, and Prof. Th. Bächi from the EM-Zentrallabor, University of Zürich, for excellent technical support and help in sample processing.

    FOOTNOTES

* This work was supported by the Amélie Waring Stiftung, the Hartmann Müller-Stiftung, and the Swiss National Science Foundation Grant 32-52661.97.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Pankreatitis-Forschungslabor, DL36, Sternwartstrasse 14, 8091 Zürich, Switzerland. Tel.: 411 255 2071; Fax: 411 255 4393; E-mail: rgf@chi.usz.ch.

Published, JBC Papers in Press, March 16, 2001, DOI 10.1074/jbc.M010717200

2 The published sequence of rat PAP II contains an error: residue 79 of the mature secreted protein is glycine rather than tryptophan and should read WIGLH. This was verified by DNA sequencing and confirmed by mass spectroscopy analysis.

3 D. Bimmler, M. Scheisser, A. Lüssi, and R. Graf, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: PSP/reg, pancreatic stone protein, regenerating protein; CTL, C-type lectin domain (Ca2+-dependent carbohydrate-recognition domain); PAP, pancreatitis-associated protein; PATP, pancreatitis-associated thread protein; PTP, pancreatic thread protein; SEM, scanning electron microscope; STEM, scanning/transmission electron microscope; PCR, polymerase chain reaction; MES, 4-morpholineethanesulfonic acid; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. De Caro, A., Lohse, J., and Sarles, H. (1979) Biochem. Biophys. Res. Commun. 87, 1176-1182[Medline] [Order article via Infotrieve]
2. Sarles, H., Dagorn, J. C., Giorgi, D., and Bernard, J. P. (1990) Gastroenterology 99, 900-901[Medline] [Order article via Infotrieve]
3. Bimmler, D., Graf, R., Scheele, G. A., and Frick, T. W. (1997) J. Biol. Chem. 272, 3073-3082[Abstract/Free Full Text]
4. De Reggi, M., Gharib, B., Patard, L., and Stoven, V. (1998) J. Biol. Chem. 273, 4967-4971[Abstract/Free Full Text]
5. Terazono, K., Uchiyama, Y., Ide, M., Watanabe, T., Yonekura, H., Yamamoto, H., and Okamoto, H. (1990) Diabetologia 33, 250-252[Medline] [Order article via Infotrieve]
6. Unno, M., Itoh, T., Watanabe, T., Miyashita, H., Moriizumi, S., Teraoka, H., Yonekura, H., and Okamoto, H. (1992) Adv. Exp. Med. Biol. 321, 61-69[Medline] [Order article via Infotrieve]
7. Watanabe, T., Yonemura, Y., Yonekura, H., Suzuki, Y., Miyashita, H., Sugiyama, K., Moriizumi, S., Unno, M., Tanaka, O., Kondo, H., Bone, A. J., Takasawa, S., and Okamoto, H. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3589-3592[Abstract]
8. Zenilman, M. E., Magnuson, T. H., Swinson, K., Egan, J., Perfetti, R., and Shuldiner, A. R. (1996) Gastroenterology 110, 1208-1214[Medline] [Order article via Infotrieve]
9. Fukui, H., Kinoshita, Y., Maekawa, T., Okada, A., Waki, S., Hassan, S., Okamoto, H., and Chiba, T. (1998) Gastroenterology 115, 1483-1493[Medline] [Order article via Infotrieve]
10. Gross, D. J., Weiss, L., Reibstein, I., van den Brand, J., Okamoto, H., Clark, A., and Slavin, S. (1998) Endocrinology 139, 2369-2374[Abstract/Free Full Text]
11. Kobayashi, S., Akiyama, T., Nata, K., Abe, M., Tajima, M., Shervani, N. J., Unno, M., Matsuno, S., Sasaki, H., Takasawa, S., and Okamoto, H. (2000) J. Biol. Chem. 275, 10723-10736[Abstract/Free Full Text]
12. Livesey, F. J., O'Brien, J. A., Li, M., Smith, A. G., Murphy, L. J., and Hunt, S. P. (1997) Nature 390, 614-618[CrossRef][Medline] [Order article via Infotrieve]
13. Bimmler, D., Angst, E., Valeri, V., Bain, M., Scheele, G. A., Frick, T. W., and Graf, R. (1999) Pancreas 19, 255-267[Medline] [Order article via Infotrieve]
14. Iovanna, J., Orelle, B., Keim, V., and Dagorn, J.-C. (1991) J. Biol. Chem. 266, 24664-24669[Abstract/Free Full Text]
15. Frigerio, J. M., Dusetti, N. J., Keim, V., Dagorn, J. C., and Iovanna, J. L. (1993) Biochemistry 32, 9236-9241[Medline] [Order article via Infotrieve]
16. Frigerio, J. M., Dusetti, N. J., Garrido, P., Dagorn, J. C., and Iovanna, J. L. (1993) Biochim. Biophys. Acta 1216, 329-331[Medline] [Order article via Infotrieve]
17. Keim, V., Rohr, G., Stockert, H. G., and Haberich, F. J. (1984) Digestion 29, 242-249[Medline] [Order article via Infotrieve]
18. Keim, V., Iovanna, J. L., Orelle, B., Verdier, J. M., Busing, M., Hopt, U., and Dagorn, J. C. (1992) Gastroenterology 103, 248-254[Medline] [Order article via Infotrieve]
19. Iovanna, J., Frigerio, J. M., Dusetti, N., Ramare, F., Raibaud, P., and Dagorn, J. C. (1993) Pancreas 8, 597-601[Medline] [Order article via Infotrieve]
20. Keim, V., Iovanna, J. L., and Dagorn, J. C. (1994) Digestion 55, 65-72[Medline] [Order article via Infotrieve]
21. Bimmler, D., Schiesser, M., Angst, E., Bain, M., Frick, T. W., and Graf, R. (1999) Pancreas 19, 416[CrossRef]
22. Gross, J., Carlson, R. I., Brauer, A. W., Margolies, M. N., Warshaw, A. L., and Wands, J. R. (1985) J. Clin. Invest. 76, 2115-2126[Medline] [Order article via Infotrieve]
23. Gross, J., Brauer, A. W., Bringhurst, R. F., Corbett, C., and Margolies, M. N. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 5627-5631[Abstract]
24. Bimmler, D., Frick, T. W., and Scheele, G. A. (1995) Pancreas 11, 63-76[Medline] [Order article via Infotrieve]
25. Schiesser, M., Bimmler, D., Frick, T. W., and Graf, R. (2001) Pancreas 22, 186-192[CrossRef][Medline] [Order article via Infotrieve]
26. Heery, D. M., Gannon, F., and Powell, R. (1990) Trends Genet. 6, 173-175[CrossRef][Medline] [Order article via Infotrieve]
27. Brenner, S., and Horne, W. R. (1959) Biochim. Biophys. Acta 34, 103-110
28. Feng, D. F., and Doolittle, R. F. (1987) J. Mol. Evol. 25, 351-360[Medline] [Order article via Infotrieve]
29. Drickamer, K. (1993) Curr. Opin. Struct. Biol. 3, 393-400
30. Scheele, G. A. (1975) J. Biol. Chem. 250, 5375-5385[Abstract]
31. Scheele, G., Bartelt, D., and Bieger, W. (1981) Gastroenterology 80, 461-473[Medline] [Order article via Infotrieve]
32. Stephanova, E., Tissir, F., Dusetti, N., Iovanna, J., Szpirer, J., and Szpirer, C. (1996) Cytogenet. Cell Genet. 72, 83-85[Medline] [Order article via Infotrieve]
33. Keim, V., and Loffler, H. G. (1986) Clin. Physiol. Biochem. 4, 136-142[Medline] [Order article via Infotrieve]
34. Keim, V., Iovanna, J.-L., Rohr, G., Usadel, K. H., and Dagorn, J.-C. (1991) Gastroenterology 100, 775-782[Medline] [Order article via Infotrieve]
35. Iovanna, J. L., Keim, V., Michel, R., and Dagorn, J. C. (1991) Am. J. Physiol. 261, G485-G489[Abstract/Free Full Text]
36. Satomura, Y., Sawabu, N., Ohta, H., Watanabe, H., Yamakawa, O., Motoo, Y., Okai, T., Toya, D., Makino, H., and Okamoto, H. (1993) Int. J. Pancreatol. 13, 59-67[Medline] [Order article via Infotrieve]
37. Su, S. B., Motoo, Y., Xie, M. J., Sakai, J., Taga, H., and Sawabu, N. (1999) Pancreas 19, 239-247[Medline] [Order article via Infotrieve]
38. Keim, V., Hoffmeister, A., Teich, N., Halm, U., Scheurlen, M., Tannapfel, A., and Mossner, J. (1999) Pancreas 19, 248-254[Medline] [Order article via Infotrieve]
39. Bimmler, D., Schiesser, M., Scheele, G. A., Frick, T. W., and Graf, R. (1999) Digestion 60, 369
40. Smith, F. E., Bonner, W. S., Leahy, J. L., Laufgraben, M. J., Ogawa, Y., Rosen, K. M., and Villa, K. L. (1994) Diabetologia 37, 994-999[CrossRef][Medline] [Order article via Infotrieve]
41. Rafaeloff, R., Pittenger, G. L., Barlow, S. W., Qin, X. F., Yan, B., Rosenberg, L., Duguid, W. P., and Vinik, A. I. (1997) J. Clin. Invest. 99, 2100-2109[Abstract/Free Full Text]
42. Sasahara, K., Yamaoka, T., Moritani, M., Yoshimoto, K., Kuroda, Y., and Itakura, M. (2000) Biochim. Biophys. Acta 1500, 142-146[Medline] [Order article via Infotrieve]
43. Cerini, C., Peyrot, V., Garnier, C., Duplan, L., Veesler, S., Le-Caer, J. P., Bernard, J. P., Bouteille, H., Michel, R., Vazi, A., Dupuy, P., Michel, B., Berland, Y., and Verdier, J. M. (1999) J. Biol. Chem. 274, 22266-22274[Abstract/Free Full Text]
44. Githens, S. (1993) in The Pancreas, Biology, Pathobiology, and Disease (Go, V. L. W. , DiMagno, E. P. , Gardner, J. D. , Lebenthal, E. , Reber, H. A. , and Scheele, G. A., eds) , pp. 21-55, Raven Press, Ltd., New York


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.